Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release

Cited by (723)

Items 201–300 of 723

1. High mobility group box 1 skews macrophage polarization and negatively influences phagocytosis of apoptotic cells
   Fleur Schaper, Karina de Leeuw, Gerda Horst, Hendrika Bootsma, Pieter C. Limburg, Peter Heeringa, Marc Bijl, Johanna Westra · 2016 · Lara D. Veeken
2. Expression of Concern: HMGB 1 mediates splenomegaly and expansion of splenic CD 11b+ L y‐6 C high inflammatory monocytes in murine sepsis survivors
   Sergio Iván Valdés‐Ferrer, Mauricio Rosas‐Ballina, Peder S. Olofsson, Ben Lü, Meghan E. Dancho, Mahendar Ochani, J. H. Li, Joshua A. Scheinerman, D. A. Katz, Yaakov A. Levine et al. · 2013 · Journal of Internal Medicine
3. Stress disinhibits microglia via down-regulation of CD200R: A mechanism of neuroinflammatory priming
   Matthew G. Frank, Laura K. Fonken, Jessica L. Annis, Linda R. Watkins, Steven F. Maier · 2017 · Brain Behavior and Immunity
4. Inflammation, DAMPs, Tumor Development, and Progression: A Vicious Circle Orchestrated by Redox Signaling
   Patrizia Castellani, Enrica Balza, Anna Rubartelli · 2013 · Antioxidants and Redox Signaling
5. The Expression of HMGB1 on Microparticles Released during Cell Activation and Cell Death In Vitro and In Vivo
   David S. Pisetsky · 2014 · Molecular Medicine
6. Targeting necroptosis in muscle fibers ameliorates inflammatory myopathies
   Mari Kamiya, Fumitaka Mizoguchi, Kimito Kawahata, Dengli Wang, Masahiro Nishibori, Jessica Alice Day, Cynthia Louis, Ian P. Wicks, Hitoshi Kohsaka, Shinsuke Yasuda · 2022 · Nature Communications
7. The Role of HMGB1 in Cardiovascular Biology: Danger Signals
   Jingjing Cai, Juan Wen, Eileen Maria Bauer, Hua Zhong, Hong Yuan, Alex F. Chen · 2015 · Antioxidants and Redox Signaling
8. HMGB1-Driven Inflammation and Intimal Hyperplasia After Arterial Injury Involves Cell-Specific Actions Mediated by TLR4
   Jingjing Cai, Hong Yuan, Qingde Wang, Huan Yang, Yousef Al‐Abed, Hua Zhong, Jie‐Mei Wang, Dandan Chen, Jinze Wu, Ben Lü et al. · 2015 · Arteriosclerosis Thrombosis and Vascular Biology
9. Life after death: targeting high mobility group box 1 in emergent cancer therapies.
   Zong Sheng Guo, Zuqiang Liu, David L. Bartlett, Daolin Tang, Michael T. Lotze · 2013 · Europe PMC (PubMed Central)
10. Post-Translational Modification of HMGB1 Disulfide Bonds in Stimulating and Inhibiting Inflammation
    Jan Andersson, Kevin J. Tracey, Huan Yang · 2021 · Cells
11. High-Mobility Group Box 1-Induced Complement Activation Causes Sterile Inflammation
    Sook Young Kim, Myoungsun Son, Sang Eun Lee, In Ho Park, Man Sup Kwak, Myeonggil Han, Hyun Sook Lee, Eun Sook Kim, Jae‐Young Kim, Jong Eun Lee et al. · 2018 · Frontiers in Immunology
12. HMGB1: A New Target for Ischemic Stroke and Hemorrhagic Transformation
    Jiamin Li, Zixin Wang, Jiameng Li, Haiping Zhao, Qingfeng Ma · 2024 · Translational Stroke Research
13. The danger-associated molecular pattern HMGB1 mediates the neuroinflammatory effects of methamphetamine
    Matthew G. Frank, Sweta Adhikary, Julia L. Sobesky, Michael D. Weber, Linda R. Watkins, Steven F. Maier · 2015 · Brain Behavior and Immunity
14. Surrogate Fecal Biomarkers in Inflammatory Bowel Disease: Rivals or Complementary Tools of Fecal Calprotectin?
    Mirko Di Ruscio, Filippo Vernia, Anna Maria Ciccone, Giuseppe Frieri, Giovanni Latella · 2017 · Inflammatory Bowel Diseases
15. Expatiating the molecular approaches of HMGB1 in diabetes mellitus: Highlighting signalling pathways via RAGE and TLRs
    Tapan Behl, Eshita Sharma, Aayush Sehgal, Ishnoor Kaur, Arun Kumar, Rashmi Arora, Giridhari Pal, Munish Kakkar, Ravinder Kumar Kaundal, SIMONA GABRIELA BUNGAU · 2021 · Molecular Biology Reports
16. High-mobility group box 1 serves as an inflammation driver of cardiovascular disease
    Abdul Wahid, Wei Chen, Xuewen Wang, Xiaohong Tang · 2021 · Biomedicine & Pharmacotherapy
17. From bench to bedside and back again: translational research in autoinflammation
    Dirk Holzinger, Christoph Kessel, Alessia Omenetti, Marco Gattorno · 2015 · Nature Reviews Rheumatology
18. High Mobility Group Box-1 (HMGB1): A Potential Target in Therapeutics
    Eyaldeva C. Vijayakumar, Lokesh Kumar Bhatt, Kedar S. Prabhavalkar · 2019 · Current Drug Targets
19. Immunogenic cell death and its therapeutic or prognostic potential in high-grade glioma
    Brecht Decraene, Yihan Yang, Frederik De Smet, Abhishek Dinkarnath Garg, Patrizia Agostinis, Steven De Vleeschouwer · 2022 · Genes and Immunity
20. An Overview on Immunogenic Cell Death in Cancer Biology and Therapy
    Mosar Corrêa Rodrigues, José Athayde Vasconcelos Morais, Rayane Ganassin, Giulia Rosa Tavares Oliveira, Fabiana Chagas Costa, Amanda Alencar Cabral Morais, Ariane Pandolfo Silveira, Victor Carlos Mello da Silva, João Paulo Figueiró Longo, Luís Alexandre Muehlmann · 2022 · Pharmaceutics
21. AMPK regulates immunometabolism in sepsis
    Jun Xing Huang, Ke Liu, Shan Zhu, Min Xie, Rui Kang, Lizhi Cao, Daolin Tang · 2017 · Brain Behavior and Immunity
22. Glycyrrhizin Inhibits PEDV Infection and Proinflammatory Cytokine Secretion via the HMGB1/TLR4-MAPK p38 Pathway
    Ruyi Gao, Yongshuai Zhang, Yuhui Kang, Weiyin Xu, Luyao Jiang, Tingting Guo, Changchao Huan · 2020 · International Journal of Molecular Sciences
23. Structure and Functions of HMGB2 Protein
    Tatiana Yu. Starkova, Alexander M. Polyanichko, Alexey N. Tomilin, Elena V. Chikhirzhina · 2023 · International Journal of Molecular Sciences
24. HMGB1 induces hepcidin upregulation in astrocytes and causes an acute iron surge and subsequent ferroptosis in the postischemic brain
    Dashdulam Davaanyam, Hahnbi Lee, Song-I Seol, Sang-A Oh, Seung-Woo Kim, Ja-Kyeong Lee · 2023 · Experimental & Molecular Medicine
25. High-Mobility Group Box 1 (HMGB1) Is Elevated Systemically in Persons with Acute or Chronic Traumatic Spinal Cord Injury
    Angelos Papatheodorou, Adam Stein, Matthew A. Bank, Cristina P. Sison, Katie Gibbs, Peter Davies, Ona Bloom · 2016 · Journal of Neurotrauma
26. Redox Regulation of Inflammatory Processes Is Enzymatically Controlled
    Inken Lorenzen, L. Mullen, Sander Bekeschus, Eva-Maria Hanschmann · 2017 · Oxidative Medicine and Cellular Longevity
27. Extracorporeal liver assist device to exchange albumin and remove endotoxin in acute liver failure: Results of a pivotal pre-clinical study
    Karla C L Lee, Luisa A. Baker, Giacomo Stanzani, Hatim IK Alibhai, Yu Mei Chang, Carolina Palacios, Pamela J. Leckie, Paola Giordano, Simon Lawrence Priestnall, Daniel James Antoine et al. · 2015 · Journal of Hepatology
28. The Alarmin HMGN1 Contributes to Antitumor Immunity and Is a Potent Immunoadjuvant
    Feng Wei, De Yang, Poonam Tewary, Yana Li, Sandra Li, Xin Chen, O. M. Zack Howard, Michael Bustin, Joost J. Oppenheim · 2014 · Cancer Research
29. Circulating HMGB1 and RAGE as Clinical Biomarkers in Malignant and Autoimmune Diseases
    Christin Pilzweger, Stefan Holdenrieder · 2015 · Diagnostics
30. High Mobility Group Box 1 in Human Cancer
    Bernardo Leon Rapoport, Helen C. Steel, Annette J. Theron, Liezl Heyman, Teresa Smit, Yastira Ramdas, Ronald Anderson · 2020 · Cells
31. High-mobility group box 1 protein (HMGB1) neutralization ameliorates experimental autoimmune encephalomyelitis
    Andrew P. Robinson, Matthew W. Caldis, Christopher T. Harp, Gwen E. Goings, Stephen D. Miller · 2013 · Journal of Autoimmunity
32. Purinergic receptor X7 is a key modulator of metabolic oxidative stress-mediated autophagy and inflammation in experimental nonalcoholic steatohepatitis
    Suvarthi Das, Ratanesh Kumar Seth, Ashutosh Kumar, Maria B. Kadiiska, Gregory Alexander Michelotti, Anna Mae Diehl, Saurabh Chatterjee · 2013 · American Journal of Physiology-Gastrointestinal and Liver Physiology
33. Post-translational modifications of high mobility group box 1 and cancer.
    Seidu A. Richard, Yuanyuan Jiang, Lu Hong Xiang, Shanshan Zhou, Jia Wang, Zhaoliang Su, Huaxi Xu · 2017 · PubMed Central
34. Immunogenicity of necrotic cell death
    Jaba Gamrekelashvili, Tim F. Greten, Firouzeh Korangy · 2014 · Cellular and Molecular Life Sciences
35. HMGB1 Protein
    Iva Ugrinova, Evdokia Alexandrova Pasheva · 2016 · Advances in protein chemistry and structural biology
36. Glycyrrhizic acid ameliorates the kynurenine pathway in association with its antidepressant effect
    Bo Wang, Yong‐Jie Lian, Xin Wen Dong, Peng Wei, Lin-Lin Liu, Wenjun Su, Hong Gong, Ting Zhang, Chun‐Lei Jiang, Jiasi Li et al. · 2018 · Behavioural Brain Research
37. Hypochlorous acid derived from microglial myeloperoxidase could mediate high-mobility group box 1 release from neurons to amplify brain damage in cerebral ischemia–reperfusion injury
    Shuang Chen, Jingrui Pan, Zhe Gong, Meiling Wu, Xiaoni Zhang, Hansen Chen, Dan Yang, Suhua Qi, Ying Peng, Jiangang Shen · 2024 · Journal of Neuroinflammation
38. Microbe- and danger-induced inflammation
    Achille Broggi, Francesca Granucci · 2014 · Molecular Immunology
39. Immunothrombotic Activity of Damage-Associated Molecular Patterns and Extracellular Vesicles in Secondary Organ Failure Induced by Trauma and Sterile Insults
    John C. Eppensteiner, Robert Patrick Davis, Andrew S. Barbas, Jean Kwun, Jae Woo Lee · 2018 · Frontiers in Immunology
40. Doxorubicin induced immune abnormalities and inflammatory responses via HMGB1, HIF1-α and VEGF pathway in progressive of cardiovascular damage
    Ahmad Syukri, Budu Budu, Mochammad Hatta, Muzakkir Amir, Mohammad Saifur Rohman, Idar Mappangara, Cahyono Kaelan, Siti Wahyuni, Agussalim Bukhari, Ade Rifka Junita et al. · 2022 · Annals of Medicine and Surgery
41. Molecular determinants of immunogenic cell death elicited by radiation therapy
    Claudia Galassi, Vanessa Klapp, Takahiro Yamazaki, Lorenzo Galluzzi · 2023 · Immunological Reviews
42. Alarmins and Antitumor Immunity
    Yingjie Nie, De Yang, Joost J. Oppenheim · 2016 · Clinical Therapeutics
43. Redox Signaling in Diabetic Nephropathy: Hypertrophy versus Death Choices in Mesangial Cells and Podocytes
    Gina Manda, Ionel Alexandru Checheriţă, Maria Victoria Comanescu, Mihail Eugen Hinescu · 2015 · Mediators of Inflammation
44. Lupus erythematosus revisited
    Annegret Kuhn, Joerg Wenzel, Marc Bijl · 2015 · Seminars in Immunopathology
45. Modulation of Chemokine Responses: Synergy and Cooperativity
    Amanda E. I. Proudfoot, Mariagrazia Uguccioni · 2016 · Frontiers in Immunology
46. Regulation of Vascular Function and Inflammation via Cross Talk of Reactive Oxygen and Nitrogen Species from Mitochondria or NADPH Oxidase—Implications for Diabetes Progression
    Andreas Daiber, Sebastian Steven, Ksenija Vujačić-Mirski, Sanela Kalinovic, Matthias Walter Oelze, Fabio Di Lisa, Thomas F. Münzel · 2020 · International Journal of Molecular Sciences
47. Sex-dependent role of microglia in disulfide high mobility group box 1 protein-mediated mechanical hypersensitivity
    Nilesh M. Agalave, Resti Rudjito, Alex Bersellini Farinotti, Payam Emami Khoonsari, Katalin Sándor, Yuki Nomura, Thomas A. Szabo-Pardi, Carlos Eduardo Morado-Urbina, Vinko Palada, Theodore John Price et al. · 2020 · Pain
48. The SIRT1-HMGB1 axis: Therapeutic potential to ameliorate inflammatory responses and tumor occurrence
    Lanyi Wei, Wenrui Zhang, Yueyang Li, Jinghui Zhai · 2022 · Frontiers in Cell and Developmental Biology
49. DAMPs in immunosenescence and cancer
    Fangquan Chen, Hu Tang, Xiutao Cai, Junhao Lin, Rui Kang, Daolin Tang, Jiao Liu · 2024 · Seminars in Cancer Biology
50. HMGB1 Levels Are Increased in Patients with Juvenile Idiopathic Arthritis, Correlate with Early Onset of Disease, and Are Independent of Disease Duration
    Hanna Schierbeck, Rille Pullerits, Chris Pruunsild, Marie Fischer, Dirk Holzinger, Åsa Laestadius, Erik Sundberg, Helena Erlandsson Harris · 2013 · The Journal of Rheumatology
51. Genomic Analysis and Differential Expression of HMG and S100A Family in Human Arthritis: Upregulated Expression of Chemokines, IL-8 and Nitric Oxide by HMGB1
    Ashok R. Amin, Abul Bashar Mir Md. Khademul Islam · 2014 · DNA and Cell Biology
52. Ménage à Trois in stress: DAMPs, redox and autophagy
    Guanqiao Li, Daolin Tang, Michael T. Lotze · 2013 · Seminars in Cancer Biology
53. The Translocation of Nuclear Molecules During Inflammation and Cell Death
    David S. Pisetsky · 2013 · Antioxidants and Redox Signaling
54. Functional Diversity of Non-Histone Chromosomal Protein HmgB1
    Elena V. Chikhirzhina, Tatiana Yu. Starkova, Anton Beljajev, Alexander M. Polyanichko, Alexey N. Tomilin · 2020 · International Journal of Molecular Sciences
55. Recent Developments in the Role of High-Mobility Group Box 1 in Systemic Lupus Erythematosus
    Fleur Schaper, Johanna Westra, Marc Bijl · 2014 · Molecular Medicine
56. Dipotassium Glycyrrhizate Inhibits HMGB1-Dependent Inflammation and Ameliorates Colitis in Mice
    Roberta Vitali, Francesca Palone, Salvatore Cucchiara, Anna Negroni, Leonardo Cavone, Manuela Costanzo, Marina Aloi, Anna Dilillo, Laura Stronati · 2013 · PLoS ONE
57. Redox-Mediated Mechanisms Fuel Monocyte Responses to CXCL12/HMGB1 in Active Rheumatoid Arthritis
    Valentina Cecchinato, Gianluca D’Agostino, Lorenzo Raeli, Alessandra Nerviani, Milena Schiraldi, Gabriela Danelon, Antonio Manzo, Marcus Thelen, Adrian Ciurea, Marco Emilio Bianchi et al. · 2018 · Frontiers in Immunology
58. HMGB1: an overview of its versatile roles in the pathogenesis of colorectal cancer
    Kim Jun Cheng, Mohammed Abdullah Alshawsh, Elsa Haniffah Mejia Mohamed, Surendran Thavagnanam, Ajantha Sinniah, Zaridatul Aini Ibrahim · 2019 · Cellular Oncology
59. Neurogenesis after traumatic brain injury - The complex role of HMGB1 and neuroinflammation
    Susruta Manivannan, Omar Marei, Omar Elalfy, Malik Zaben · 2020 · Neuropharmacology
60. IL‐1β/HMGB1 Complexes Promote The PGE2 Biosynthesis Pathway in Synovial Fibroblasts
    Pauline M. Leclerc, Heidi Wähämaa, Helena Idborg, Per‐Johan Jakobsson, Helena Erlandsson Harris, Marina Korotkova · 2013 · Scandinavian Journal of Immunology
61. Sex- and cell-dependent contribution of peripheral high mobility group box 1 and TLR4 in arthritis-induced pain
    Resti Rudjito, Nilesh M. Agalave, Alex Bersellini Farinotti, Peter Lundbäck, Thomas A. Szabo-Pardi, Theodore John Price, Helena Erlandsson Harris, Michael D. Burton, Camilla I. Svensson · 2020 · Pain
62. Rebalancing expression of HMGB1 redox isoforms to counteract muscular dystrophy
    Giorgia Careccia, Marielle Saclier, Mario Tirone, Elena Ruggieri, Elisa Principi, Lizzia Raffaghello, Silvia Torchio, Deborah Recchia, Monica Canepari, Andrea Gorzanelli et al. · 2021 · Science Translational Medicine
63. HMGB1 as an extracellular pro-inflammatory cytokine: Implications for drug-induced organic damage
    Jianye Yuan, Lin Guo, JiaTing Ma, HeJian Zhang, MingXuan Xiao, Ning Li, Hui Gong, Miao Yan · 2024 · Cell Biology and Toxicology
64. The complex role of DNA, histones and HMGB1 in the pathogenesis of SLE
    David S. Pisetsky · 2014 · Autoimmunity
65. Targeting Cell Death and Sterile Inflammation Loop for the Treatment of Nonalcoholic Steatohepatitis
    Alexander Wree, Wajahat Zafar Mehal, Ariel E. Feldstein · 2016 · Seminars in Liver Disease
66. Redox‐regulation of activator protein 1 family members in blood cancer cell lines exposed to cold physical plasma‐treated medium
    Anke Schmidt, Katrin Rödder, Sybille Hasse, Kai Masur, Lena Toups, Christopher Horst Lillig, Thomas von Woedtke, Kristian Wende, Sander Bekeschus · 2016 · Plasma Processes and Polymers
67. Neuroinflammation in Response to Intracerebral Injections of Different HMGB1 Redox Isoforms
    Hannah Aucott, Johan Lundberg, Henna Salo, Lena Klevenvall, Peter Damberg, Lars Ottosson, Ulf Andersson, Staffan Holmin, Helena Erlandsson Harris · 2018 · Journal of Innate Immunity
68. Oxidation of HMGB1 Is a Dynamically Regulated Process in Physiological and Pathological Conditions
    Michele Ferrara, Ginevra Chialli, Lorena Maria Ferreira, Elena Ruggieri, Giorgia Careccia, Alessandro Preti, Rosanna Piccirillo, Marco Emilio Bianchi, Giovanni Sitia, Emilie Vénéreau · 2020 · Frontiers in Immunology
69. Recent advances in biomarkers and therapeutic interventions for hepatic drug safety – false dawn or new horizon?
    Joanna I. Clarke, James W. Dear, Daniel James Antoine · 2016 · Expert Opinion on Drug Safety
70. Molecular Actors of Inflammation and Their Signaling Pathways: Mechanistic Insights from Zebrafish
    Jade Leiba, Resul Özbilgiç, Liz Hernández, Maria Demou, Georges Lutfalla, Laure Yatime, Mai Nguyen Chi · 2023 · Biology
71. Diflunisal targets the HMGB1/CXCL12 heterocomplex and blocks immune cell recruitment
    Federica De Leo, Giacomo Quilici, Mario Tirone, Francesco De Marchis, Valeria Mannella, Chiara Zucchelli, Alessandro Preti, Alessandro Gori, Maura Casalgrandi, Rosanna Mezzapelle et al. · 2019 · EMBO Reports
72. Biological functions and theranostic potential of HMGB family members in human cancers
    Liaoran Niu, Wanli Yang, Lili Duan, Xiaoqian Wang, Yiding Li, Chengchao Xu, Chao Liu, Yujie Zhang, Wei Jie Zhou, Jinqiang Liu et al. · 2020 · Therapeutic Advances in Medical Oncology
73. Tumor-intrinsic determinants of immunogenic cell death modalities
    Samuel Tekeste Workenhe, Jonathan G. Pol, Guido Kroemer · 2021 · OncoImmunology
74. High Systemic Levels of the Cytokine-Inducing HMGB1 Isoform Secreted in Severe Macrophage Activation Syndrome
    Karin Palmblad, Hanna Schierbeck, Erik Sundberg, AnnaCarin Horne, Helena Erlandsson Harris, Jan‐Inge Henter, Daniel James Antoine, Ulf Andersson · 2014 · Molecular Medicine · Retracted
75. Glycyrrhizin inhibits porcine epidemic diarrhea virus infection and attenuates the proinflammatory responses by inhibition of high mobility group box-1 protein
    Changchao Huan, Hua-xia Wang, Xiang-xiang Sheng, Rui Wang, Xin Wang, Xiang Mao · 2017 · Archives of Virology
76. Targeting danger molecules in tendinopathy: the HMGB1/TLR4 axis
    Moeed Akbar, Derek S. Gilchrist, Susan M. Kitson, Briana Nelis, Lindsay A. N. Crowe, Emma García Melchor, James H. Reilly, Shauna C. Kerr, George A.C. Murrell, Iain B. McInnes et al. · 2017 · RMD Open
77. Non-oxidizable HMGB1 induces cardiac fibroblasts migration via CXCR4 in a CXCL12-independent manner and worsens tissue remodeling after myocardial infarction
    Stefania Di Maggio, Giuseppina Milano, Francesco De Marchis, Alessandro D’Ambrosio, Matteo Bertolotti, Blanca Soler Palacios, Ileana Badi, Elena Sommariva, Giulio Pompilio, Maurizio Colognesi Capogrossi et al. · 2017 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
78. Oxaliplatin-induced changes in microbiota, TLR4+ cells and enhanced HMGB1 expression in the murine colon
    Vanesa Stojanovska, Rachel Mai McQuade, Sarah Fraser, Monica D. Prakash, Shakuntla V. Gondalia, Rhian G Stavely, Enzo A. Palombo, Vasso Apostolopoulos, Samy Sakkal, Kulmira Nurgali · 2018 · PLoS ONE
79. RETRACTED: Exploring the therapeutic promise of targeting HMGB1 in rheumatoid arthritis
    Ishnoor Kaur, Tapan Behl, SIMONA GABRIELA BUNGAU, Arun Kumar, Vineet Mehta, Dhruv Setia, Md. Sahab Uddin, Gökhan Zengin, Lotfi Aleya, Sandeep Arora · 2020 · Life Sciences · Retracted
80. Molecular insights into the therapeutic promise of targeting HMGB1 in depression
    Tarapati Rana, Tapan Behl, Vineet Mehta, Md. Sahab Uddin, SIMONA GABRIELA BUNGAU · 2020 · Pharmacological Reports
81. HMGB1-mediated restriction of EPO signaling contributes to anemia of inflammation
    Brian M. Dulmovits, Yuefeng Tang, Julien Papoin, Mingzhu He, Jianhua Li, Huan Yang, Meghan E. Addorisio, Lauren Paige Kennedy, Mushran Khan, Elena C. Brindley et al. · 2022 · Blood
82. 5‐Fluorouracil causes leukocytes attraction in the peritoneal cavity by activating autophagy and HMGB1 release in colon carcinoma cells
    Lucia Cottone, Annalisa Capobianco, Chiara Gualteroni, Cristiana Perrotta, Marco Emilio Bianchi, Patrizia Querini Rovere, Angelo Andrea Manfredi · 2014 · International Journal of Cancer
83. Neurons Are a Primary Driver of Inflammation via Release of HMGB1
    Huan Yang, Jan Andersson, Michael L. Brines · 2021 · Cells
84. How macrophages ring the inflammation alarm
    Marco Emilio Bianchi, Angelo Andrea Manfredi · 2014 · Proceedings of the National Academy of Sciences
85. Damage-associated molecular patterns and their role as initiators of inflammatory and auto-immune signals in systemic lupus erythematosus
    Karen Álvarez, Gloria M Vásquez · 2017 · International Reviews of Immunology
86. Epidermal HMGB1 Activates Dermal Fibroblasts and Causes Hypertrophic Scar Formation in Reduced Hydration
    Jingling Zhao, Jianxing Yu, Yingbin Xu, Lei Chen, Fei Zhou, Qiyi Zhai, Jun Wu, Bin Shu, Shaohai Qi · 2018 · Journal of Investigative Dermatology
87. Natural modulators of the hallmarks of immunogenic cell death
    Flavia Radogna, Mario A. Dicato, Marc F. Diederich · 2019 · Biochemical Pharmacology
88. Cell-Death-Associated Molecular Patterns As Determinants of Cancer Immunogenicity
    S. Ladoire, D. Hannani, M. Vetizou, C. Locher, L. Aymeric, L. Apetoh, O. Kepp, G. Kroemer, F. Ghiringhelli, L. Zitvogel · 2014 · Antioxidants and Redox Signaling
89. Leukocyte HMGB1 Is Required for Vessel Remodeling in Regenerating Muscles
    Lara Campana, Francesco Santarella, Antonio Esposito, Norma Maugeri, Elena Rigamonti, Antonella Monno, Tamara Canu, Alessandro Del Maschio, Marco Emilio Bianchi, Angelo Andrea Manfredi et al. · 2014 · The Journal of Immunology
90. High Mobility Group Box-1 and Diabetes Mellitus Complications: State of the Art and Future Perspectives
    Federico Biscetti, Maria Margherita Rando, Elisabetta Nardella, Andrea Leonardo Cecchini, Giovanni Pecorini, Raffaele Landolfi, Andrea Flex · 2019 · International Journal of Molecular Sciences
91. HMGB1 amplifies ILC2-induced type-2 inflammation and airway smooth muscle remodelling
    Zhixuan Loh, Jennifer Simpson, Md Ashik Ullah, Vivian Zhang, Wan Jun Gan, Jason P. Lynch, Rhiannon B. Werder, Md Al Amin Sikder, Katie Lane, Choon Boon Sim et al. · 2020 · PLoS Pathogens
92. Mitochondrial Reactive Oxygen Species and Lytic Programmed Cell Death in Acute Inflammation
    Sergio Rius‐Pérez, Salvador Pérez, Michel B. Tolédano, Juan Sastre · 2023 · Antioxidants and Redox Signaling
93. Neutrophil extracellular traps are a source of extracellular HMGB1 in lupus nephritis: associations with clinical and histopathological features
    Laura Patricia Whittall Garcia, Jiram José Torres-Ruiz, Alejandro Zentella‐Dehesa, Miguel Tapia Rodríguez, Jorge Carlos Alcocer-Varela, Néstor Veriel Méndez Huerta, Diana Gómez‐Martín · 2019 · Lupus
94. Extracellular HMGB1 regulates multi-walled carbon nanotube-induced inflammation in vivo
    Forrest Jessop, Andrij Holian · 2014 · Nanotoxicology
95. Asbestos-Induced Chronic Inflammation in Malignant Pleural Mesothelioma and Related Therapeutic Approaches—A Narrative Review
    Zolondick, Alicia A., Gaudino, Giovanni, Xue, Jiaming, Pass, Harvey I., Carbone, Michele, Yang, Haining · 2021 · Precision Cancer Medicine
96. HMGB1-Mediated Activation of the Inflammatory-Reparative Response Following Myocardial Infarction
    Eleonora Foglio, Laura Pellegrini, Matteo Antonio Russo, Federica Limana · 2022 · Cells
97. Translational and Clinical Significance of DAMPs, PAMPs, and PRRs in Trauma-induced Inflammation
    Vikrant Rai, Gillian Mathews, Devendra K. Agrawal · 2022 · Archives of Clinical and Biomedical Research
98. Therapeutic Opportunities in Damage-Associated Molecular Pattern-Driven Metabolic Diseases
    Irma García‐Martinez, Mohamed E. Shaker, Wajahat Zafar Mehal · 2015 · Antioxidants and Redox Signaling
99. Vascular Remodelling and Mesenchymal Transition in Systemic Sclerosis
    Pier Andrea Nicolosi, Enrico Tombetti, Norma Maugeri, Patrizia Querini Rovere, Silvia Brunelli, Angelo Andrea Manfredi · 2016 · Stem Cells International
100. HMGB1 is a promising therapeutic target for acute liver failure
     Tetsu Yamamoto, Yoshitsugu Tajima · 2017 · Expert Review of Gastroenterology & Hepatology